Literature DB >> 11825569

Assembly and antigen-presenting function of MHC class I molecules in cells lacking the ER chaperone calreticulin.

Bin Gao1, Raju Adhikari, Mark Howarth, Kimitoshi Nakamura, Marielle C Gold, Ann B Hill, Rai Knee, Marek Michalak, Tim Elliott.   

Abstract

MHC class I molecules expressed in a calreticulin-deficient cell line (K42) assembled with beta 2-microglobulin (beta2-m) normally, but their subsequent loading with optimal peptides was defective. Suboptimally loaded class I molecules were released into the secretory pathway. This occurred despite the ability of newly synthesized class I to interact with the transporter associated with antigen processing (TAP) loading complex. The efficiency of peptide loading was reduced by 50%-80%, and impaired T cell recognition was observed for three out of four antigens tested. The peptide-loading function was specific to calreticulin, since the defect in K42 could be rectified by transfection with calreticulin but not a soluble form of calnexin, which shares its lectin-like activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11825569     DOI: 10.1016/s1074-7613(01)00260-6

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  75 in total

1.  The oxidoreductase ERp57 efficiently reduces partially folded in preference to fully folded MHC class I molecules.

Authors:  Antony N Antoniou; Stuart Ford; Magnus Alphey; Andrew Osborne; Tim Elliott; Simon J Powis
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

Review 2.  Innate self recognition by an invariant, rearranged T-cell receptor and its immune consequences.

Authors:  Aleksandar K Stanic; Jang-June Park; Sebastian Joyce
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

Review 3.  The multi-faceted nature of HLA class I dimer molecules.

Authors:  Elaine C Campbell; Antony N Antoniou; Simon J Powis
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

4.  The polypeptide binding conformation of calreticulin facilitates its cell-surface expression under conditions of endoplasmic reticulum stress.

Authors:  Elise Jeffery; Larry Robert Peters; Malini Raghavan
Journal:  J Biol Chem       Date:  2010-11-12       Impact factor: 5.157

Review 5.  Assembly of MHC class I molecules within the endoplasmic reticulum.

Authors:  Yinan Zhang; David B Williams
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 6.  Pathogen evasion strategies for the major histocompatibility complex class I assembly pathway.

Authors:  Antony N Antoniou; Simon J Powis
Journal:  Immunology       Date:  2008-02-18       Impact factor: 7.397

7.  The redox activity of ERp57 is not essential for its functions in MHC class I peptide loading.

Authors:  David R Peaper; Peter Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-23       Impact factor: 11.205

8.  Modes of calreticulin recruitment to the major histocompatibility complex class I assembly pathway.

Authors:  Natasha Del Cid; Elise Jeffery; Syed Monem Rizvi; Ericca Stamper; Larry Robert Peters; William Clay Brown; Chester Provoda; Malini Raghavan
Journal:  J Biol Chem       Date:  2009-12-03       Impact factor: 5.157

9.  Endoplasmic reticulum chaperones stabilize ligand-receptive MR1 molecules for efficient presentation of metabolite antigens.

Authors:  Hamish E G McWilliam; Jeffrey Y W Mak; Wael Awad; Matthew Zorkau; Sebastian Cruz-Gomez; Hui Jing Lim; Yuting Yan; Sam Wormald; Laura F Dagley; Sidonia B G Eckle; Alexandra J Corbett; Haiyin Liu; Shihan Li; Scott J J Reddiex; Justine D Mintern; Ligong Liu; James McCluskey; Jamie Rossjohn; David P Fairlie; Jose A Villadangos
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-21       Impact factor: 11.205

Review 10.  What is the role of alternate splicing in antigen presentation by major histocompatibility complex class I molecules?

Authors:  Alan Belicha-Villanueva; Jennifer Blickwedehl; Sarah McEvoy; Michelle Golding; Sandra O Gollnick; Naveen Bangia
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.